Hormone replacement therapy and risk for neurodegenerative diseases. - Wikidata - wikimedia - TriplyDB

Hormone replacement therapy and risk for neurodegenerative diseases.

Hormone replacement therapy and risk for neurodegenerative diseases.

http://www.wikidata.org/entity/Q35884815

about

Sex and Gender Differences in Central Nervous System-Related Disorders Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study Brain sex matters: estrogen in cognition and Alzheimer's disease Sex differences in cognitive impairment and Alzheimer's disease.Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies Language performance in postmenopausal women with and without hormone therapy and men.Not all depression is created equal: sex interacts with disease to precipitate depression Nutraceuticals against Neurodegeneration: A Mechanistic Insight.Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.Genetic Architecture of Sexual Dimorphism in Humans.L-Type Calcium Channels Modulation by Estradiol.In Silico Investigation of the Pharmacological Mechanisms of Beneficial Effects of Ginkgo biloba L. on Alzheimer's Disease.Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease

P2860

Q26744569-5456A33F-1DCB-4325-9866-6F9CAABB3F56 Q28546721-E96FE2B0-AA3B-4300-B5F5-EDFC68C265A1 Q33693268-6181FF74-C910-4B2B-9A2B-7863D32973EC Q33864547-EF6A8F31-4BA2-4C96-B957-8CCF45693D18 Q35049313-4ACF00AA-78DF-4C73-B96D-A30BE7E5E408 Q35095659-4CB23AD6-5430-4743-93A2-6FAF503DBE8F Q36803388-03B2B876-9B2A-4808-A1F8-5F9E8835C36D Q37168739-35A58B2C-697F-4C88-8978-E4F2FC84F376 Q37416371-81FC9AFD-9A84-4AA4-BD47-11A65AD586DA Q38367724-988D3EDB-C91F-483D-9EC7-42BB79FF7119 Q38831286-44686A93-D3AB-45D3-A369-B00353095EE2 Q55137583-2AFFCCAD-B9EA-40B4-86F5-F868BCC5B615 Q57816569-C09007ED-B6B5-4B9E-A709-D97A7DBA6A2D

P2860

Hormone replacement therapy and risk for neurodegenerative diseases.

http://www.wikidata.org/entity/Q35884815

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Hormone replacement therapy and risk for neurodegenerative diseases.

@ast

Hormone replacement therapy and risk for neurodegenerative diseases.

@en

type

label

Hormone replacement therapy and risk for neurodegenerative diseases.

@ast

Hormone replacement therapy and risk for neurodegenerative diseases.

@en

prefLabel

Hormone replacement therapy and risk for neurodegenerative diseases.

@ast

Hormone replacement therapy and risk for neurodegenerative diseases.

@en

P1433

Q35884815-0F098882-79B0-4810-9540-A55CDE420132

P1476

Q35884815-562B2B0D-D5DA-497A-8B4B-C7D5F1992A8C

P2093

Q35884815-A9F74B18-0D51-4241-A962-C96CCF97D6FD

Q35884815-B17DF2E4-E25F-46B4-BBCD-39887FF037AF

Q35884815-B300A1F5-3709-49DD-8579-8519DF813B7B

P2860

Q35884815-030B2539-CD9B-4D88-B1E3-EB7AE859B39A

Q35884815-065368DD-0E78-4A31-B7C4-C2BB58379CE2

Q35884815-06A0F693-9E86-40A7-83C0-8F5CB8131563

Q35884815-07A03BED-0DB3-4AF8-9250-4B3D3BA90990

Q35884815-08FFFDE3-3180-4C1A-8C09-0EF1D6BED4DC

Q35884815-0C06A749-F0B6-42EC-BCF9-9DD509747643

Q35884815-0E83FF62-1F95-4C0A-98D7-43D2EFC77A49

Q35884815-0F22C848-199A-4CF5-9805-961A83222C1A

Q35884815-0FEE0E74-38E1-4C80-BB96-8CABA371770F

Q35884815-14030A7A-BB71-4E30-90B7-686F2059C33B

P304

Q35884815-95BE1722-AD79-48B2-9DD5-5DA799487C77

P31

Q35884815-EF53FD5E-38E1-406D-86D3-5F1B815AD165

P356

Q35884815-5476339E-1887-4345-B75F-344C55EEDB83

P478

Q35884815-DAF75222-E6E0-44AF-8648-899C397193FF

P50

Q35884815-8C18B0E3-5166-44D5-88D7-A7A2D6CFE3C8

P577

Q35884815-2197200E-20F1-43A4-B759-804397E7EA43

P5875

Q35884815-FE0FEC76-4FBF-488E-8E49-3EB2917C72DE

P698

Q35884815-6CC5365E-877E-4F40-8B62-D7FA3B122992

P921

Q35884815-EB121441-ABA1-40E4-A24F-1829D94CC906

P932

Q35884815-244D6B57-08CD-4B40-ADE6-3CAEA8112DA4

P356

P1433

International journal of Alzheimer's disease

P1476

Hormone replacement therapy and risk for neurodegenerative diseases

@en

P2093

Andrew J Levine

http://www.w3.org/2001/XMLSchema#string

Elyse J Singer

http://www.w3.org/2001/XMLSchema#string

Karen J Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

Increased cardiovascular mortality after early bilateral oophorectomy

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment

Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions

Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

Epidemiology of Parkinson's disease

Are men at greater risk for Parkinson's disease than women?

Postmenopausal estrogen use affects risk for Parkinson disease.

A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease.

P304

258454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/258454

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224872051

http://www.w3.org/2001/XMLSchema#string

P698

22548198

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

3324889

http://www.w3.org/2001/XMLSchema#string